ZLZengqing Liu

Zengqing Liu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Zengqing Liu has a total of 23 co-authors. Here are the top co-authors by number of shared publications:

  • Chen Chen

    School of Biomedical Sciences, The University of Queensland, Brisbane, QLD 4072, Australia

    1 shared publication
  • Chris J. Corrigan

    Faculty of Life Sciences & Medicine School of Immunology & Microbial Sciences King's College London London UK

    1 shared publication
  • Fanyu Shi

    Department of Immunology School of Basic Medical Sciences Capital Medical University Beijing China

    1 shared publication
  • Huanyu Long

    Department of Pulmonary and Critical Care Medicine Peking University Third Hospital Beijing China

    1 shared publication
  • Hui Deng

    Biomedical Innovation Center Beijing Shijitan Hospital Capital Medical University Beijing China

    1 shared publication
  • Jiajia Wang

    Biomedical Innovation Center Beijing Shijitan Hospital Capital Medical University Beijing China

    1 shared publication

Latest Publications

  • Open Access

    Single‐Cell RNA Sequencing of Human Lung Tissues Reveals Metallothionein‐Positive T Cells as a Novel Potential Marker of Susceptibility to Chronic Obstructive Pulmonary Disease

    by Zengqing Liu, Xiaoxia Ren, Mi Mu, Huanyu Long, Jialu Lv, Zhihong Feng, Jie Liu, Jiajia Wang, Hui Deng, Fanyu Shi, et al.

    Chronic obstructive pulmonary disease (COPD) is a highly heterogeneous disease with complex pathogenesis. Identifying high‐risk populations and implementing timely prevention strategies are critical to reducing the disease burden. Single‐cell RNA sequencing of lung tissue from control never‐smokers, patients with pre‐COPD, and COPD patients revealed a novel T cell subset characterized by high expression of metallothionein (MT) genes, designated MT‐high T cells. These cells were progressively depleted in the lungs with disease progression. A similar decline was observed in the peripheral blood using flow cytometry, highlighting the potential of these cells to serve as an accessible biomarker of disease progression. Functional analysis indicated that MT‐high T cells suppress CD8 + T cell cytotoxic activity, suggesting a key immunoregulatory role in disease pathogenesis. Receiver operating characteristic curve analysis demonstrated the excellent potential of MT‐high T cell frequency to predict susceptibility to COPD. These findings establish MT‐high T cells as promising biomarkers for identifying individuals at risk for COPD and as novel targets for future therapeutic and prophylactic strategies.